Challenges of Diagnosing Pediatric Posterior Reversible Encephalopathy Syndrome in Resource Poor Settings: A

Ikenna Kingsley Ndu1, Adaeze Chikaodinaka Ayuk2, Vivian Ozoemena Onukwuli2

  • 1Enugu State University of Science and Technology, Enugu, Nigeria.

Global Pediatric Health
|August 28, 2020
PubMed

Insights

Posterior reversible encephalopathy syndrome (PRES) is a rare neurological condition affecting children and adults. Early diagnosis and management are crucial, especially in resource-poor settings where diagnostic challenges exist.

Area of Science:

  • Neurology
  • Pediatrics

Background:

  • Posterior reversible encephalopathy syndrome (PRES) is a rare neurological condition affecting various age groups, including children.
  • Common triggers include immunosuppressive agents, organ transplantation, sepsis, blood transfusions, and HIV-1 infection.
  • PRES typically presents with reversible clinical and radiological findings over days to weeks.

Purpose of the Study:

  • To highlight the potential occurrence of pediatric PRES.
  • To identify factors hindering diagnosis in resource-limited settings.
  • To increase pediatrician awareness for timely diagnosis and management.

Main Methods:

  • This narrative review synthesizes existing literature on pediatric PRES.
  • It focuses on triggers, diagnostic challenges, and management considerations.
  • The review emphasizes the need for increased awareness in resource-poor environments.

Main Results:

  • PRES is observed across different age groups, with specific triggers identified in children and adults.
  • While CT scans aid diagnosis, MRI is the gold standard.
  • Diagnostic challenges are exacerbated in developing countries due to equipment costs.

Conclusions:

  • Increased awareness of pediatric PRES is vital for early detection and intervention.
  • Addressing diagnostic barriers in resource-poor settings is essential for equitable care.
  • Further research on pediatric PRES in underserved populations is warranted.

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...